Product Categories

Akt Inhibitors

Akt Inhibitors (15)

water-soluble

Cat.No. Product Name Information Product Citations Customer Reviews
S1078 MK-2206 2HCl MK-2206 2HCl is a highly selective inhibitor of Akt1, Akt2 and Akt3 with IC50 of 8 nM, 12 nM and 65 nM, respectively.
S1037 Perifosine Perifosine (KRX-0401) is a novel Akt inhibitor with IC50 of 4.7 μM.
S1113 GSK690693 GSK690693 is a pan-Akt inhibitor targeting Akt1, Akt2 and Akt3 with IC50 of 2 nM, 13 nM, and 9 nM, respectively.
S2808 GDC-0068 GDC-0068 is a highly selective pan-Akt inhibitor targeting Akt1, Akt2 and Akt3 with IC50 of 5 nM, 18 nM and 8 nM, respectively.
S2743 PF-04691502 PF-04691502 is an ATP-competitive, selective inhibitor of PI3K(α/β/δ/γ)/mTOR with Ki of 1.8 nM/2.1 nM/1.6 nM/1.9 nM and 16 nM, also inhibits Akt phosphorylation on T308/S473 with IC50 of 7.5 nM/3.8 nM.
S7127 TIC10 TRAIL-inducing compound 10 (TIC10) is a potent, orally active, and stable small molecule that transcriptionally induces TRAIL in a p53-independent manner and crosses the blood-brain barrier.
S1558 AT7867 AT7867 is a potent ATP-competitive inhibitor of Akt1/2/3 and S6K with IC50 of 32 nM/17 n/47 nM and 85 nM, respectively.
S1117 Triciribine Triciribine (TCN, API-2) is a DNA synthesis inhibitor and also inhibits Akt and HIV-1 with IC50 of 130 nM and 20 nM, respectively.
S8019 AZD5363 AZD5363 is a potent Akt inhibitor for Akt1, Akt2 and Akt3 with IC50 of 3 nM, 8 nM and 8 nM, respectively.
S3056 Miltefosine (Hexadecylphosphocholine) Miltefosine inhibits PI3K/Akt activity with ED50 of 17.2 μM and 8.1 μM in carcinoma cell lines A431 and HeLa.
S2732 Triciribine phosphate (NSC-280594) Triciribine phosphate (TCN-P, NSC-280594, API-2) is a potent Akt inhibitor with IC50 of 130 nM.
S2670 A-674563 A-674563 inhibits Akt1, PKA and CDK2 with Ki of 11 nM, 16 nM and 46 nM, respectively.
S2635 CCT128930 CCT128930 is a potent, ATP-competitive and selective inhibitor of Akt2 with IC50 of 6 nM.
S2310 Honokiol Honokiol is a biphyl neolignan present in the cones, bark, and leaves of Magnolia grandifloris that displays antiangiogenic, antiinflammatory, and antitumor properties due to the inhibitory effect on the PI3K/Akt pathway.
S1556 PHT-427 PHT-427 is a dual Akt and PDPK1 inhibitor with Ki of 2.7 μM and 5.2 μM, respectively.
Tags: AKT Inhibitors | akt1 inhibitor | akt2 inhibitor | akt3 inhibitor | Akt inhibitor | Akt1 inhibitor | Akt2 inhibitor | Akt3 inhibitor | specific Akt inhibitor | FDA approved Akt inhibitor | selective Akt inhibitors | pan Akt inhibitor | ATP-competitive Akt inhibitor